These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 27007879)

  • 1. Recombinant canarypox virus expressing the VP2 protein of infectious bursal disease virus induces protection in vaccinated SPF chickens.
    Zanetti FA; Cardona R; Federico CR; Chimeno-Zoth S; Calamante G
    Virol Sin; 2016 Jun; 31(3):266-9. PubMed ID: 27007879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Canarypox virus expressing infectious bursal disease VP2 protein as immunogen for chickens.
    Zanetti FA; Grand MD; Mitarotonda RC; Taboga OA; Calamante G
    Braz J Microbiol; 2014; 45(1):231-4. PubMed ID: 24948937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection against infectious bursal disease virulent challenge conferred by a recombinant avian adeno-associated virus vaccine.
    Perozo F; Villegas P; Estevez C; Alvarado IR; Purvis LB; Williams S
    Avian Dis; 2008 Jun; 52(2):315-9. PubMed ID: 18646463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Avian adenovirus CELO recombinants expressing VP2 of infectious bursal disease virus induce protection against bursal disease in chickens.
    Francois A; Chevalier C; Delmas B; Eterradossi N; Toquin D; Rivallan G; Langlois P
    Vaccine; 2004 Jun; 22(17-18):2351-60. PubMed ID: 15149796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of VP2 protein expressed in E. coli for protection against highly virulent infectious bursal disease virus.
    Omar AR; Kim CL; Bejo MH; Ideris A
    J Vet Sci; 2006 Sep; 7(3):241-7. PubMed ID: 16871018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complete, long-lasting protection against lethal infectious bursal disease virus challenge by a single vaccination with an avian herpesvirus vector expressing VP2 antigens.
    Tsukamoto K; Saito S; Saeki S; Sato T; Tanimura N; Isobe T; Mase M; Imada T; Yuasa N; Yamaguchi S
    J Virol; 2002 Jun; 76(11):5637-45. PubMed ID: 11991992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of recombinant VP2 vaccine for the prevention of infectious bursal disease of chickens.
    Rong J; Cheng T; Liu X; Jiang T; Gu H; Zou G
    Vaccine; 2005 Sep; 23(40):4844-51. PubMed ID: 15979770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutralizing-antibody-mediated protection of chickens against infectious bursal disease via one-time vaccination with inactivated recombinant Lactococcus lactis expressing a fusion protein constructed from the RCK protein of Salmonella enterica and VP2 of infectious bursal disease virus.
    Wang W; Song Y; Liu L; Zhang Y; Wang T; Zhang W; Li K; Qi X; Gao Y; Gao L; Liu C; Zhang Y; Wang Y; Pan Q; He G; Wang X; Cui H
    Microb Cell Fact; 2019 Jan; 18(1):21. PubMed ID: 30704494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a tailored vaccine against challenge with very virulent infectious bursal disease virus of chickens using reverse genetics.
    Gao L; Qi X; Li K; Gao H; Gao Y; Qin L; Wang Y; Wang X
    Vaccine; 2011 Jul; 29(33):5550-7. PubMed ID: 21658423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Large-scale manufacture and use of recombinant VP2 vaccine against infectious bursal disease in chickens.
    Rong J; Jiang T; Cheng T; Shen M; Du Y; Li S; Wang S; Xu B; Fan G
    Vaccine; 2007 Nov; 25(46):7900-8. PubMed ID: 17923174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection of chickens, with or without maternal antibodies, against IBDV infection by a recombinant IBDV-VP2 protein.
    Zhou X; Wang D; Xiong J; Zhang P; Li Y; She R
    Vaccine; 2010 May; 28(23):3990-6. PubMed ID: 20338216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccination with E. coli recombinant empty viral particles of infectious bursal disease virus (IBDV) confer protection.
    Rogel A; Benvenisti L; Sela I; Edelbaum O; Tanne E; Shachar Y; Zanberg Y; Gontmakher T; Khayat E; Stram Y
    Virus Genes; 2003 Oct; 27(2):169-75. PubMed ID: 14501195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of two strains of Marek's disease virus serotype 1 for the development of recombinant vaccines against very virulent infectious bursal disease virus.
    Li K; Liu Y; Liu C; Gao L; Gao Y; Zhang Y; Cui H; Qi X; Zhong L; Wang X
    Antiviral Res; 2017 Mar; 139():153-160. PubMed ID: 27908832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasmid DNA encoding antigens of infectious bursal disease viruses induce protective immune responses in chickens: factors influencing efficacy.
    Li J; Huang Y; Liang X; Lu M; Li L; Yu L; Deng R
    Virus Res; 2003 Dec; 98(1):63-74. PubMed ID: 14609631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective oral vaccination against infectious bursal disease virus using the major viral antigenic protein VP2 produced in Pichia pastoris.
    Taghavian O; Spiegel H; Hauck R; Hafez HM; Fischer R; Schillberg S
    PLoS One; 2013; 8(12):e83210. PubMed ID: 24376665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Active and passive protection against variant and classic infectious bursal disease virus strains induced by baculovirus-expressed structural proteins.
    Vakharia VN; Snyder DB; Lütticken D; Mengel-Whereat SA; Savage PK; Edwards GH; Goodwin MA
    Vaccine; 1994 Apr; 12(5):452-6. PubMed ID: 8023554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucosal application of cationic poly(D,L-lactide-co-glycolide) microparticles as carriers of DNA vaccine and adjuvants to protect chickens against infectious bursal disease.
    Negash T; Liman M; Rautenschlein S
    Vaccine; 2013 Aug; 31(36):3656-62. PubMed ID: 23777953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant Marek's disease virus type 1 provides full protection against very virulent Marek's and infectious bursal disease viruses in chickens.
    Li K; Liu Y; Liu C; Gao L; Zhang Y; Cui H; Gao Y; Qi X; Zhong L; Wang X
    Sci Rep; 2016 Dec; 6():39263. PubMed ID: 27982090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient self-assembly and protective efficacy of infectious bursal disease virus-like particles by a recombinant baculovirus co-expressing precursor polyprotein and VP4.
    Lee HJ; Kim JY; Kye SJ; Seul HJ; Jung SC; Choi KS
    Virol J; 2015 Oct; 12():177. PubMed ID: 26502988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of homologous and heterologous prime-boost immunizations combining MVA-vectored and plant-derived VP2 as a strategy against IBDV.
    Richetta M; Gómez E; Lucero MS; Chimeno Zoth S; Gravisaco MJ; Calamante G; Berinstein A
    Vaccine; 2017 Jan; 35(1):142-148. PubMed ID: 27876199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.